From omics to AI-mapping the pathogenic pathways in type 2 diabetes.

Area of Science:

• Biochemistry
• Systems Biology
• Metabolic Disease Research

Background:

• Type 2 Diabetes (T2D) pathophysiology is complex, involving intricate biochemical pathways and interorgan communication.
• Understanding molecular dysfunction is key to linking metabolic disturbances with clinical T2D phenotypes.
• Current research requires advanced methods to integrate diverse biological data for a holistic view.

Purpose of the Study:

• To synthesize current evidence on the molecular architecture of T2D.
• To highlight key biochemical pathways and cellular mechanisms driving T2D.
• To explore the integration of multi-omics and AI for advancing T2D research and therapy.

Main Methods:

• Review of multi-omics data (genomics, transcriptomics, proteomics, metabolomics, microbiomics).
• Application of single-cell technologies to identify cell-type-specific T2D drivers.
• Utilizing AI-driven analytics and machine learning for high-dimensional dataset integration.

Main Results:

• Identified key molecular pathways (e.g., PI3K-Akt, AMPK, mTOR, JNK, sirtuins) implicated in T2D.
• Highlighted the role of gut microbiota in modulating host metabolism and inflammation.
• Demonstrated the power of AI in uncovering molecular signatures and regulatory networks in T2D.

Conclusions:

• A pathway-centric systems biology approach offers mechanistic insight into T2D.
• Integrating multi-omics and AI is crucial for patient stratification and precision diabetes care.
• This approach bridges the gap between molecular research and clinical application for T2D interventions.